SecProbe.io

Probe score transparency
Intelligence Terminal Search Topics Monthly Activity About

Probe Score Transparency

Oric Pharmaceuticals, Inc. (ORIC)
Score window: Apr. 15, 2025 to Apr. 14, 2026

Back View Correspondence
Probe Score
1.5 / 10
Letters
1
Latest Activity
Jun. 17, 2025
Version
v1

Score Breakdown

Letter Count
1.0
Sentiment / Tone
0.5
Keywords
0.0
Signals
0.0
Notable 8-K Modifier
0.0
Notable 8-K Count
0

Matched Signals

No stored keyword or signal matches were recorded for this score.

Filings In This Window

DateFormSentimentUrgencySummaryOpen
Jun. 17, 2025 CORRESP Neutral/Informational Moderate ORIC Pharmaceuticals, Inc. has submitted a request to the SEC for the acceleration of their Registration Statement on Form S-3, seeking to have it declared effective by June 20, 2… Read Filing EDGAR
Jun. 16, 2025 UPLOAD Neutral/Informational Low The SEC correspondence dated June 16, 2025, informs Jacob Chacko, CEO of Oric Pharmaceuticals, that the agency has not reviewed and will not review the company's registration stat… Read Filing EDGAR

Notable 8-Ks In This Window

No notable 8-Ks were stored for this company in the score window.